Transformative innovation in fibroid treatment in the UAE
At the forefront of this change is Dr. Usha Kiran Talakere, a leading consultant gynecologist and advanced minimal access surgeon at Prime Hospital, Dubai. With decades of experience and a reputation for compassionate care, Dr. Usha is now offering microwave ablation of fibroids - a cutting-edge, uterus-sparing treatment designed to dramatically reduce symptoms with minimal downtime.
'Women no longer have to choose between enduring symptoms or undergoing major surgery,' says Dr. Usha. 'This treatment allows us to target the fibroids precisely, protect fertility, and get patients back to their lives quickly.'
A safe, effective alternative to surgery
Microwave ablation involves the use of image-guided technology to deliver focused microwave energy directly into the fibroid. The procedure, which typically takes under an hour, results in shrinkage of the fibroid tissue over a period of 3 to 6 months while preserving the uterus.
It is performed under either spinal or general anesthesia and most patients return home the next day - with full recovery expected within 72 hours.
Key advantages include no large incisions or visible scarring of uterus, no bleeding, minimal pain and reduced risk of complications, preservation of fertility for women planning pregnancies and a rapid return to normal routines
A personalised approach
Dr. Usha Kiran emphasizes that microwave ablation is not a one-size-fits-all approach. Each patient undergoes a thorough evaluation to ensure the treatment aligns with the type, size, and location of the fibroids, as well as personal reproductive goals.
'My role as a clinician is to guide women through all the options available, and microwave ablation has quickly become one of the most impactful tools in our care arsenal,' she adds.
A step forward for women's health in the UAE
With Dubai establishing itself as a center of medical excellence, the availability of microwave ablation at Prime Hospital marks another milestone in patient-centric care. Women who once postponed treatment due to fear of surgery or fertility loss now have a clinically proven option that puts their well-being first.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The National
38 minutes ago
- The National
Genetic test can improve cancer care and cut side effects
Medical researchers in the UAE are turning to genetic testing to understand more about how some patients respond to drugs so that side effects can be reduced and effectiveness improved. Pharmacogenetics is becoming more common in the treatment of cancer, depression and cardiac disease. More personalised prescriptions, rather than a one size fits all approach to medication, can improve patient care and cut costs for hospital and insurers, researchers said. Genetics play a significant role in drug response, with an estimated 70–90 per cent of drug response variability having a genetic component. More than 200 medications – including drugs for oncology, cardiology, psychiatry, pain management, and infectious diseases – come with guidelines that advise prescribing based on a person's genes. Tests costs around Dh1,000 but that is expected to come down in price as doctors predict they will become a routine aspect of care. Jen Blandos, 51, a Canadian, had a first breast cancer diagnosis in 2012 and two more cancer diagnoses after that. Her latest breast cancer treatment plan has been created using knowledge gleaned by doctors from a genetic test, allowing them to improve her care and minimise debilitating side effects of regular chemotherapy. 'Compared to my first cancer diagnosis, now there's much more detailed mapping of the cancer I have, and a number of different things doctors look at to determine the best treatment,' said Ms Blandos, who lives in Dubai and has two children. 'One of the tests is getting more comprehensive mapping done on my genes. I had genetic variants where it showed I don't metabolise certain drugs. I also have a tonne of allergies, including all opiates and pain relief except paracetamol," she said. 'I'm also allergic to all antibiotics except for one, so I'm not an easy person for doctors to treat. 'When you're put on drugs for seven years after chemotherapy, you want to make sure it's going to be the right drug and it's going to work.' Tumour test score Her most recently discovered cancer, an invasive carcinoma, was picked up in a routine check in April. Doctors took a blood test and biopsy of her tumour to understand more about the kind of care she would most respond to. The test is based on the activity of 21 genes in the tumour tissue and gives an indication of how likely the cancer will respond to chemotherapy, or return in the future. It helped doctors decide on 12 courses of chemotherapy. 'Like anybody who's had cancer, universally we all worry about it returning,' said Ms Blandos. 'We try to put it to the back of our minds. I'm aware there is potential for genetic data to be misused, and there could be future problems. 'But I know the genetic testing that I need allows insurers to have access to that information, which makes me cheaper as a patient for them as they're not wasting money on treatments I don't necessarily need.' There is particular value to genetic testing of patients with chronic health conditions who are prescribed multiple medications. Personalised medicine is becoming more common in every-day care. Ravi Sharma, chief pharmacy officer at Burjeel Holdings, said genetic testing could become a routine part of prescriptions. 'Medicines are one of the most common interventions in healthcare, and what's really interesting is that from the evidence, 30 to 60 per cent of patients may not always respond commonly as we predict to these medicines,' he said. 'We would like this to be a pre-test for patients getting their routine care, to enable us throughout their whole healthcare journey to prescribe optimally according to their genomic response.' Within 20 years, more than 90 per cent of patient populations across the world will find at least one drug that has a pharmaco-genomic gene relationship, doctors said. Treatments could be optimised in a number of fields, such as psychiatry, hypertension, endocrinology, opioid use and management, and oncology. Hassan Jaafar, consultant in medical oncology and medical director at Burjeel Cancer Institute, said pharmaco-genomics is playing a major role in his clinical management. 'Even within the same ethnicity, there are different hereditary backgrounds which make certain drugs metabolise faster in the liver, and even in other parts of the tissue,' he said. 'It's important to identify the sensitivity and the toxicity of chemotherapeutic agents or any other drugs. 'The approach for those patients, the outcome, the prognosis can be completely different if you identify them and approach them differently to the standard treatment.' More efficient prescribing Genetic testing can also streamline prescribing to reduce hospital admissions with better use of medicines, allowing doctors to deliver more sustained continuity of care. A typical test involves a blood sample processed in a lab, with the genetic information integrated into a patient's health records. When a doctor comes to prescribe medication, they would receive an alert displaying a patient's clinical parameters and suitability for drugs. Mohammad Fityan, chief medical officer at Burjeel Medical City, said patients currently have to pay for the Dh1000 test, but it could soon become available under health insurance. 'By doing this test, not only we will make sure that the medicine will work, but it will work safely and with fewer side effects,' he said. 'In patients with depression, we can try some medication and it takes us up to six weeks before we know whether it will work effectively or not. 'We have all these drug resources, now it's about how to use them effectively in a smart way that will serve our patients the best.'
The National
38 minutes ago
- The National
Doctors turn to genetic tests to improve cancer care and cut side effects
Medical researchers in the UAE are turning to genetic testing to understand more about how some patients respond to drugs so that side effects can be reduced and effectiveness improved. Pharmacogenetics is becoming more common in the treatment of cancer, depression and cardiac disease. More personalised prescriptions, rather than a one size fits all approach to medication, can improve patient care and cut costs for hospital and insurers, researchers said. Genetics play a significant role in drug response, with an estimated 70–90 per cent of drug response variability having a genetic component. More than 200 medications – including drugs for oncology, cardiology, psychiatry, pain management, and infectious diseases – come with guidelines that advise prescribing based on a person's genes. Tests costs around Dh1,000 but that is expected to come down in price as doctors predict they will become a routine aspect of care. Jen Blandos, 51, a Canadian, had a first breast cancer diagnosis in 2012 and two more cancer diagnoses after that. Her latest breast cancer treatment plan has been created using knowledge gleaned by doctors from a genetic test, allowing them to improve her care and minimise debilitating side effects of regular chemotherapy. 'Compared to my first cancer diagnosis, now there's much more detailed mapping of the cancer I have, and a number of different things doctors look at to determine the best treatment,' said Ms Blandos, who lives in Dubai and has two children. 'One of the tests is getting more comprehensive mapping done on my genes. I had genetic variants where it showed I don't metabolise certain drugs. I also have a tonne of allergies, including all opiates and pain relief except paracetamol," she said. 'I'm also allergic to all antibiotics except for one, so I'm not an easy person for doctors to treat. 'When you're put on drugs for seven years after chemotherapy, you want to make sure it's going to be the right drug and it's going to work.' Tumour test score Her most recently discovered cancer, an invasive carcinoma, was picked up in a routine check in April. Doctors took a blood test and biopsy of her tumour to understand more about the kind of care she would most respond to. The test is based on the activity of 21 genes in the tumour tissue and gives an indication of how likely the cancer will respond to chemotherapy, or return in the future. It helped doctors decide on 12 courses of chemotherapy. 'Like anybody who's had cancer, universally we all worry about it returning,' said Ms Blandos. 'We try to put it to the back of our minds. I'm aware there is potential for genetic data to be misused, and there could be future problems. 'But I know the genetic testing that I need allows insurers to have access to that information, which makes me cheaper as a patient for them as they're not wasting money on treatments I don't necessarily need.' There is particular value to genetic testing of patients with chronic health conditions who are prescribed multiple medications. Personalised medicine is becoming more common in every-day care. Ravi Sharma, chief pharmacy officer at Burjeel Holdings, said genetic testing could become a routine part of prescriptions. 'Medicines are one of the most common interventions in healthcare, and what's really interesting is that from the evidence, 30 to 60 per cent of patients may not always respond commonly as we predict to these medicines,' he said. 'We would like this to be a pre-test for patients getting their routine care, to enable us throughout their whole healthcare journey to prescribe optimally according to their genomic response.' Within 20 years, more than 90 per cent of patient populations across the world will find at least one drug that has a pharmaco-genomic gene relationship, doctors said. Treatments could be optimised in a number of fields, such as psychiatry, hypertension, endocrinology, opioid use and management, and oncology. Hassan Jaafar, consultant in medical oncology and medical director at Burjeel Cancer Institute, said pharmaco-genomics is playing a major role in his clinical management. 'Even within the same ethnicity, there are different hereditary backgrounds which make certain drugs metabolise faster in the liver, and even in other parts of the tissue,' he said. 'It's important to identify the sensitivity and the toxicity of chemotherapeutic agents or any other drugs. 'The approach for those patients, the outcome, the prognosis can be completely different if you identify them and approach them differently to the standard treatment.' More efficient prescribing Genetic testing can also streamline prescribing to reduce hospital admissions with better use of medicines, allowing doctors to deliver more sustained continuity of care. A typical test involves a blood sample processed in a lab, with the genetic information integrated into a patient's health records. When a doctor comes to prescribe medication, they would receive an alert displaying a patient's clinical parameters and suitability for drugs. Mohammad Fityan, chief medical officer at Burjeel Medical City, said patients currently have to pay for the Dh1000 test, but it could soon become available under health insurance. 'By doing this test, not only we will make sure that the medicine will work, but it will work safely and with fewer side effects,' he said. 'In patients with depression, we can try some medication and it takes us up to six weeks before we know whether it will work effectively or not. 'We have all these drug resources, now it's about how to use them effectively in a smart way that will serve our patients the best.'
The National
an hour ago
- The National
What is 'sleep divorce' and how can you make it work?
For the past decade, Courtney Brandt and her husband of 20 years have been sleeping in separate rooms at their Dubai villa. They've been practising what's sometimes referred to as 'sleep divorce' or couples sleeping apart in order to improve their rest – and their relationship. 'I am generally a terrible sleeper, so rather than keep my husband awake, I chose to permanently remove myself. And it worked out well because I go to bed quite early and I like to keep a very cool room,' the content creator and author tells The National. 'We spend a third of our lives sleeping, so I can't stress how important it is. And sleeping apart has zero to do with the status of your relationship and everything to do with your ability to sleep.' Brandt and her husband are not alone. With our relentless schedules and constant glowing screens, good quality sleep has quietly become a luxury. This has led to a growing number of couples embracing sleep divorce, experts say. 'I estimate that slightly more than one of the three patients who have requested a consultation for a sleep disorder in the past year have already resorted to a sleep divorce,' says Dr Valentina Faia, specialist psychiatrist and psychotherapist at BPS Clinic Dubai. According to a 2023 survey by the American Academy of Sleep Medicine, which polled 2,005 adults in the US, 58 per cent of respondents said they adjusted their sleep routines to accommodate a partner. In the same survey, 20 per cent said they occasionally slept in another room while 15 per cent said they consistently slept in a separate room. 'Studies of sleep patterns or polysomnography have shown that co-sleeping couples often experience more short-lasting awakenings throughout the night than those sleeping separately, and a generally lower quality of sleep,' says Dr Faia. 'When couples share a bed, disturbances from a partner can lead to fragmented sleep cycles and reduced sleep efficiency.' Dr Sudhanthira Devi Ramdoss, a specialist psychiatrist at Aster Hospital in Dubai, says she's also seen a rising number of cases where her clients practice sleep divorce. Despite its negative connotation – and when practised correctly – sleep divorce can lead to improved relationships, better mood regulation, increased patience and more positive interactions during the day, she says. 'It's a lifestyle choice that prioritises good quality sleep, reduced sleep interruptions and reduced irritability,' says Dr Ramdoss. 'At the end of a long day, if you are not able to sleep adequately or tossing and turning in the bed throughout the night, it will leave you drained in the morning. This can be a sticking point in an otherwise healthy relationship between couples. 'By practicing sleep divorce with mutual consent, couples will have improved quality of sleep, improved relationships and increased intimacy.' Others are curious to experiment with the rising trend, with space being the only hold back. Kellie Whitehead, 47, a mother-of-three, who has been married for 25 years, says she would do it if she had the space 'for better rest and nothing else'. 'I'm older now and each hour counts more – against work, stresses and health concerns. I simply can't function well daily without a certain amount of good sleep,' says the PR consultant. 'I've never been able to sleep well 'entangled' or nose-to-nose with anyone else – husband or children.' Yet, despite the rising number of cases she's seeing, Dr Faia says she only recommends sleep divorce to couples when there's a documented medical condition and the other partner has shown significant distress. 'It's often not easy to open up about this habit for someone who has embraced it, as it challenges traditional conceptions of cohabitation and at times even questions moral or religious beliefs,' she says. 'Some individuals equate sleeping together with intimacy, security and love. Sometimes, the physical separation triggers unresolved attachment issues. 'Typical conditions that lead to sleep divorce are obstructive sleep apnoea, snoring, periodic limb movement disorder and severely mismatched circadian rhythms. These issues can significantly reduce sleep quality, even when individuals are unaware of the disturbances,' Dr Faia adds. Making sleep divorce work To successfully practice a sleep divorce, communication is key, says Dr Ramdoss. 'Sleep divorce is not about ending a relationship, it's just a practical choice to deal with sleep issues. So have an open communication about your sleep needs and concerns with your partner and obtain mutual consent,' she says. 'Go for a trial period like practising two to three times per week or practice sleep divorce on weekdays. Create a comfortable space for sleep, and preserve bedtime rituals like cuddling and sharing parts of your day to maintain closeness and intimacy.' Dr Faia often recommends hybrid solutions to her clients. 'These include the Scandinavian method of using separate blankets or sleeping in the same bed but with custom mattresses or earplugs, or scheduling alone-sleep nights interspersed with co-sleep nights,' she says. 'These alternatives provide flexibility while maintaining a sense of closeness and intimacy and protecting the time couples can spend together.' Dubai resident Rima, who prefers to go by her first name, swears by the Scandinavian method – something she and her husband have been practicing since they got married 18 years ago. 'I like to cocoon myself in my blanket when I sleep, which means I like to tuck my blanket in around me,' says the marketing consultant and mother-of-two. 'Also because our room is like the North Pole at night I get cold quickly and so my blanket is thicker than my husband's. 'The freedom of moving around without bothering the other person, and also feeling like I have my own space on our bed is the best feeling.' Brandt also suggests starting out with something less permanent. 'The key is to really define the two spaces, if you are fortunate enough to have a second room. If you don't have that, you can always do two duvets, which can help in creating that space,' she says. Brandt, whose rescue dog Poppy splits her time between her and husband at night, says their sleep set-up is a permanent arrangement and something she has no problem sharing with friends. 'Sleep is paramount to living, especially in today's world,' she says. 'People might give me weird looks for sleeping apart, but I know how good I'm sleeping.'
